GW Pharma CEO explains company's plan for CBD-based epilepsy drug
lifestyle April 15th. 2023, 2:42pm
GW Pharmaceuticals CEO Justin Gover tells Jim Cramer the company plans to launch the first CBD-based epilepsy drug in Europe ‘over the next year or two.’

Compensation Disclosure
-
This site receives compensation for referred sales of some or all mentioned products.